Literature DB >> 10657835

Mitochondrial respiratory chain complex I deficiency with clinical and biochemical features of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.

G M Enns1, M J Bennett, C L Hoppel, S I Goodman, K Weisiger, C Ohnstad, M Golabi, S Packman.   

Abstract

The mitochondrial respiratory chain and the fatty acid oxidation cycle are theoretically interdependent on each other for normal function. We describe a patient with complex I deficiency who had clinical and biochemical features of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency including liver failure, cardiomyopathy, and consistent urine organic acid pattern. Patients with features of either a respiratory chain or fatty acid oxidation disorder should have the defect characterized biochemically because of the implications with respect to potential therapy and genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657835     DOI: 10.1016/s0022-3476(00)70111-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 2.  Treatment options for lactic acidosis and metabolic crisis in children with mitochondrial disease.

Authors:  Katharina Danhauser; Jan A M Smeitink; Peter Freisinger; Wolfgang Sperl; Hemmen Sabir; Berit Hadzik; Ertan Mayatepek; Eva Morava; Felix Distelmaier
Journal:  J Inherit Metab Dis       Date:  2015-02-17       Impact factor: 4.982

Review 3.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

4.  Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes.

Authors:  Yudong Wang; Al-Walid Mohsen; Stephanie J Mihalik; Eric S Goetzman; Jerry Vockley
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

Review 5.  The elusive magic pill: finding effective therapies for mitochondrial disorders.

Authors:  Amy Goldstein; Lynne A Wolfe
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

6.  Mutation analysis of copper transporter genes in patients with ethylmalonic encephalopathy, mitochondriopathies and copper deficiency phenotypes.

Authors:  X Fu; P Rinaldo; S H Hahn; H Kodama; S Packman
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 7.  Metabolism as a complex genetic trait, a systems biology approach: implications for inborn errors of metabolism and clinical diseases.

Authors:  Jerry Vockley
Journal:  J Inherit Metab Dis       Date:  2008-10-05       Impact factor: 4.982

8.  Respiratory complex II defect in siblings associated with a symptomatic secondary block in fatty acid oxidation.

Authors:  J J Gargus; K Boyle; M Bocian; D S Roe; C Vianey-Saban; C R Roe
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 9.  Mitochondrial disease in childhood: nuclear encoded.

Authors:  Amy C Goldstein; Poonam Bhatia; Jodie M Vento
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

10.  Short-chain 3-hydroxyacyl-coenzyme A dehydrogenase associates with a protein super-complex integrating multiple metabolic pathways.

Authors:  Srinivas B Narayan; Stephen R Master; Anthony N Sireci; Charlene Bierl; Paige E Stanley; Changhong Li; Charles A Stanley; Michael J Bennett
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.